For The Media – JAMA Network

EMBARGOED FOR RELEASE: 3 P.M. (CT), MONDAY, SEPTEMBER 10, 2012 Archives of Neurology Study Highlights Treatment with angiotensin receptor blockers (ARBs; group of medications used in treatment of hypertension, diabetic nephropathy and congestive heart failure) among persons with hypertension is associated with less amyloid accumulation in the brain and a decreased likelihood of post-mortem neuropathologic…

EMBARGOED FOR RELEASE: 3 P.M. (CT), MONDAY, SEPTEMBER 3, 2012 Media Advisory: To contact corresponding author Lisa A. Cannon-Albright, Ph.D., call Kathy Wilets at 801-581-5717 or email kathy.wilets@hsc.utah.edu. To contact editorial author Walter A. Rocca, M.D., M.P.H., call Brian Kilen at 507-284-5005 or email newsbureau@mayo.edu. CHICAGO– A study that used a Utahgenealogic database and a…

EMBARGOED FOR RELEASE: 3 P.M. (CT), MONDAY, SEPTEMBER 3, 2012 Archives of Neurology Study Highlights A study that used a Utah genealogic database and a statewide cancer registry to examine the relationship between Parkinson disease (PD) and cancer suggests an increased risk of prostate cancer and melanoma in patients with PD and their relatives (Online…

  EMBARGOED FOR RELEASE: 3 P.M. (CT), MONDAY, AUGUST 27, 2012 Media Advisory: To contact Sara Hall, M.D., email sara.hall@med.lu.se or to contact corresponding author Oskar Hansson, M.D., Ph.D., email oskar.hansson@med.lu.se. To contact editorial author Richard J. Perrin, M.D., Ph.D., call Judy Martin Finch at 314-286-0105 or email martinju@wustl.edu. CHICAGO – A study of cerebrospinal…

EMBARGOED FOR RELEASE: 3 P.M. (CT), MONDAY, AUGUST 13, 2012 Archives of Neurology Study Highlights A phase 2 randomized study to determine the safety and tolerability of a medication called avagacestat (an oral γ-secretase inhibitor) for patients with Alzheimer disease found that in 209 patients with mild to moderate disease, the drug was well tolerated…

EMBARGOED FOR RELEASE: 3 P.M. (CT), MONDAY, AUGUST 6, 2012 Media Advisory: To contact Laura D. Baker, Ph.D., call Leila Gray at 206-685-0381 or email leilag@uw.edu. CHICAGO– Treatment with growth hormone-releasing hormone appears to be associated with favorable cognitive effects among both adults with mild cognitive impairment and healthy older adults, according to a randomized…

EMBARGOED FOR RELEASE: 3 P.M. (CT), MONDAY, JULY 23, 2012 Archives of Neurology Study Highlights Shortening of chromosomal telomeres, which provide a protective role for genetic material, is a consequence of cell division. The findings of a study of 1,983 people (average age 78.3 years) enrolled in a population-based study of aging and dementia in…

EMBARGOED FOR RELEASE: 3 P.M. (CT), MONDAY, JULY 16, 2012 Archives of Neurology Study Highlights A study describes a panel of plasma biomarkers that researchers suggest may distinguish patients with Alzheimer disease (AD), a progressive neurodegenerative disease, from cognitively healthy individuals. Researchers comment that the biomarkers identified in the analysis of data from the Australian…

  EMBARGOED FOR RELEASE: 3 P.M. (CT), MONDAY, JULY 9, 2012 Media Advisory: To contact William L. Palmer, M.A., M.Sc., email w.palmer07@imperial.ac.uk. CHICAGO– A study of patients with stroke admitted to English National Health Service public hospitals suggests that patients who were hospitalized on weekends were less likely to receive urgent treatments and had worse outcomes,…

EMBARGOED FOR RELEASE: 3 P.M. (CT), MONDAY, JULY 9, 2012 Archives of Neurology Study Highlights A study of patients with stroke admitted to English National Health Service public hospitals suggests that patients who were hospitalized on weekends were less likely to receive urgent treatments and had worse outcomes (Online First, see news release below). A…

EMBARGOED FOR RELEASE: 3 P.M. (CT), MONDAY, JULY 2, 2012 Media Advisory: To contact Ernst-Wilhelm Radue, M.D., email eradue@uhbs.ch. CHICAGO– The medication fingolimod reduced inflammatory lesion activity and reduced brain volume loss in patients with multiple sclerosis who participated in a two-year placebo-controlled clinical trial and were assessed by magnetic resonance imaging (MRI) measures, according…

  EMBARGOED FOR RELEASE: 3 P.M. (CT), MONDAY, JUNE 18, 2012 Media Advisory: To contact Kristine Yaffe, M.D., call Jason Bardi at 415-502-4608 or email jason.bardi@ucsf.edu. CHICAGO– Among well-functioning older adults without dementia, diabetes mellitus (DM) and poor glucose control among those with DM are associated with worse cognitive function and greater cognitive decline, according…

EMBARGOED FOR RELEASE: 3 P.M. (CT), MONDAY, JUNE 11, 2012 Archives of Neurology Study Highlights Among persons at increased genetic risk for Alzheimer disease (AD), altered patterns of inflammatory protein biomarkers in young and middle adulthood in ε4 carriers may be related to AD risk in later life, according to a study of 33 persons…

EMBARGOED FOR RELEASE: 3 P.M. (CT), MONDAY, MAY 28, 2012 Archives of Neurology Study Highlights A study of 20 patients in London who experienced acute ischemic stroke suggests vascular endothelial growth factor (VEGF) levels were significantly higher in patients who experienced ischemic stroke with cerebral microbleeds (CMBs) compared with those without CMBs. Researchers suggest that…